Tempest Therapeutics to acquire four CAR T assets in all-stock deal; CEO change, warrants issued

Tempest Therapeutics, Inc.

Acquires ERI-2003, ERI-2206, ERI-3003, ERI-3206 CAR T therapies for 8,268,495 shares of TPST common stock.
Post-closing, existing TPST holders own ~35%; Erigen equityholders (Matt Angel and Lotus Capital) own ~38% and ~27% on fully diluted basis.
Matt Angel appointed President & CEO; Stephen Brady becomes Chairman; Geoff Nichol resigns from board, effective at closing.
Each TPST share to receive one warrant exercisable at $18.48 per share, valid for 5 years from issue date.
Closing requires stockholder approval, Angel's appointment, and a minimum $5M pre-closing financing; expected early 2026.

item 1.01 item 3.02 item 5.02 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-287163
form_type: 8-K
ticker: TPST
cik: 0001544227
company_name: Tempest Therapeutics, Inc.
filed_at: 2025-11-19T23:59:59+00:00
discovered_at: 2026-05-14T18:02:39.699267+00:00
generated_at: 2026-05-16T18:26:03.015786+00:00
sec_items: ["1.01", "3.02", "5.02", "8.01", "9.01"]
event_type: m_and_a
sentiment: neutral
materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-287163
json_url: https://secwatch.observer/filing/0001193125-25-287163.json
markdown_url: https://secwatch.observer/filing/0001193125-25-287163.md
text_url: https://secwatch.observer/filing/0001193125-25-287163.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312525287163/0001193125-25-287163-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312525287163/d97617d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-25-287163

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.